|
Originally published In Press as doi:10.1074/jbc.M311430200 on March 23, 2004
J. Biol. Chem., Vol. 279, Issue 22, 23098-23103, May 28, 2004
Endothelin-1 Induces Expression of Matrix-associated Genes in Lung Fibroblasts through MEK/ERK*
Xu Shi-wen ,
Sarah L. Howat ,
Elisabetta A. Renzoni¶,
Alan Holmes ,
Jeremy D. Pearson ,
Michael R. Dashwood||,
George Bou-Gharios**,
Christopher P. Denton ,
Roland M. du Bois¶,
Carol M. Black ,
Andrew Leask  , and
David J. Abraham
From the
Centre for Rheumatology, Department of Medicine and the ||Department of Molecular Pathology, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, United Kingdom, the Centre for Cardiovascular Biology and Medicine, Guy's, King's, and St. Thomas' School of Biomedical Sciences, King's College London, Guy's Campus, London, SE1 1UL, United Kingdom, the ¶Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College School of Medicine, London SW3 6LR, United Kingdom, **Department of Medicine, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, United Kingdom
The endothelins are a family of endothelium-derived peptides that possess a variety of biological activities, including potent vasoconstriction. Endothelin-1 (ET-1) is up-regulated during tissue repair and pulmonary fibrosis. Here, we use genome-wide expression array analysis to show that the addition of ET-1 (100 nM, 4 h) to normal lung fibroblasts directly induces expression of matrix and matrix-associated genes, including the profibrotic protein CCN2 (connective tissue growth factor, or CTGF). ET-1 induces the MEK/ERK MAP kinase pathway in fibroblasts. Blockade of the MEK/ERK kinase pathway with U0126 abrogates the ability of ET-1 to induce expression of matrix and matrix-associated mRNAs and the CCN2 protein. The CCN2 promoter possesses an ET-1 response element, which maps to the previously identified basal control element-1 (BCE-1) site. Our results suggest that ET-1 induces a program of matrix synthesis in lung fibroblasts and that ET-1 may play a key role in connective tissue deposition during wound repair and in pulmonary fibrosis.
Received for publication, October 17, 2003
, and in revised form, March 22, 2004.
The Gene Expression Omnibus(GEO) series number for the expression data of this work is GSE1081.
* This work was supported by the Raynaud's and Scleroderma Association Trust, the Scleroderma Foundation, the Wellcome Trust, the Arthritis Research Campaign, the Nightingale Trust, the Welton Foundation, and the British Heart Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
 To whom correspondence should be addressed. Tel.: 207-794-0500 ext. 4053; Fax: 207-794-0432; E-mail: a.leask{at}rfc.ucl.ac.uk.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B R Klass, A O Grobbelaar, and K J Rolfe
Transforming growth factor {beta}1 signalling, wound healing and repair: a multifunctional cytokine with clinical implications for wound repair, a delicate balance
Postgrad. Med. J.,
January 1, 2009;
85(999):
9 - 14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Leask
TGF{beta}, cardiac fibroblasts, and the fibrotic response
Cardiovasc Res,
May 1, 2007;
74(2):
207 - 212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Pannu, S. Nakerakanti, E. Smith, P. t. Dijke, and M. Trojanowska
Transforming Growth Factor-beta Receptor Type I-dependent Fibrogenic Gene Program Is Mediated via Activation of Smad1 and ERK1/2 Pathways
J. Biol. Chem.,
April 6, 2007;
282(14):
10405 - 10413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Castanares, M. Redondo-Horcajo, N. Magan-Marchal, P. ten Dijke, S. Lamas, and F. Rodriguez-Pascual
Signaling by ALK5 mediates TGF-beta-induced ET-1 expression in endothelial cells: a role for migration and proliferation
J. Cell Sci.,
April 1, 2007;
120(7):
1256 - 1266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Leask and D. J. Abraham
All in the CCN family: essential matricellular signaling modulators emerge from the bunker
J. Cell Sci.,
December 1, 2006;
119(23):
4803 - 4810.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Liao, A. Schneider, N. S. Datta, and L. K. McCauley
Extracellular calcium as a candidate mediator of prostate cancer skeletal metastasis.
Cancer Res.,
September 15, 2006;
66(18):
9065 - 9073.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Nakerakanti, B. Kapanadze, M. Yamasaki, M. Markiewicz, and M. Trojanowska
Fli1 and Ets1 Have Distinct Roles in Connective Tissue Growth Factor/CCN2 Gene Regulation and Induction of the Profibrotic Gene Program
J. Biol. Chem.,
September 1, 2006;
281(35):
25259 - 25269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Shi-Wen, F. Rodriguez-Pascual, S. Lamas, A. Holmes, S. Howat, J. D. Pearson, M. R. Dashwood, R. M. du Bois, C. P. Denton, C. M. Black, et al.
Constitutive ALK5-Independent c-Jun N-Terminal Kinase Activation Contributes to Endothelin-1 Overexpression in Pulmonary Fibrosis: Evidence of an Autocrine Endothelin Loop Operating through the Endothelin A and B Receptors.
Mol. Cell. Biol.,
July 1, 2006;
26(14):
5518 - 5527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Roestenberg, F. A. van Nieuwenhoven, J. A. Joles, C. Trischberger, P. P. Martens, N. Oliver, J. Aten, J. W. Hoppener, and R. Goldschmeding
Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice
Am J Physiol Renal Physiol,
June 1, 2006;
290(6):
F1344 - F1354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Shi-wen, L. A. Stanton, L. Kennedy, D. Pala, Y. Chen, S. L. Howat, E. A. Renzoni, D. E. Carter, G. Bou-Gharios, R. J. Stratton, et al.
CCN2 Is Necessary for Adhesive Responses to Transforming Growth Factor-beta1 in Embryonic Fibroblasts
J. Biol. Chem.,
April 21, 2006;
281(16):
10715 - 10726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chen, X. Shi-wen, J. van Beek, L. Kennedy, M. McLeod, E. A. Renzoni, G. Bou-Gharios, S. Wilcox-Adelman, P. F. Goetinck, M. Eastwood, et al.
Matrix Contraction by Dermal Fibroblasts Requires Transforming Growth Factor-{beta}/Activin-Linked Kinase 5, Heparan Sulfate-Containing Proteoglycans, and MEK/ERK: Insights into Pathological Scarring in Chronic Fibrotic Disease
Am. J. Pathol.,
December 1, 2005;
167(6):
1699 - 1711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Zhou, C. Li, and L. Cai
Advanced Glycation End-Products Induce Connective Tissue Growth Factor-Mediated Renal Fibrosis Predominantly through Transforming Growth Factor {beta}-Independent Pathway
Am. J. Pathol.,
December 1, 2004;
165(6):
2033 - 2043.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|